The S&P 500 on Thursday finished right on the cusp of a critical support line that, if broken, could portend more losses for ...

Why home loan yields don’t wait around for the central bank to make a move, and how to know if it’s finally time to refinance ...

Based on cargo space, technology, features, driving performance, options, fuel economy, build, and more, these are the top ...

A trend reversal in fund-flow data may show that investors are switching their focus from tech stocks to sectors in line to ...

An exchange-traded fund that equally weights stocks in the S&P 500 index was up Friday afternoon, even as the three major U.S ...

As Cape Verde faces off against Saudi Arabia tonight, here’s a look at what could be next for the breakout World Cup star.

TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) notes with satisfaction that, in its decision issued today, the Paris Judicial Court did not uphold the claims brought by the associations and the City ...

Lantheus Holdings's new drug application was rejected by the Food and Drug Administration's due to unresolved manufacturing issues at a third-party facility. The application was for LNTH-2501, an ...

Universe Pharmaceuticals agreed to acquire Best Praise International Limited in an all-stock deal valued at $10.8 million. Universe will pay for the acquisition with about 4.8 million shares of its ...

U.S. forces launched an attack on Iran Friday, a day after Tehran struck a commercial ship that was transiting the Strait of Hormuz. "U.S. aircraft struck Iranian missile and drone storage locations ...

Yellow Corp. sustained a cyberattack last year that led to the leak of information about former employees. The company said Friday it found that certain files on its computer network were accessed and ...

Viridian Therapeutics said the U.S. Food and Drug Administration has approved Lumvoa to treat thyroid eye disease. The company said it will launch Lumvoa immediately, adding physicians can begin ...